| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.90B | 70.65B | 82.50B | 102.67B | 68.37B | 63.61B |
| Gross Profit | 37.85B | 37.88B | 33.59B | 4.72B | 19.08B | 21.60B |
| EBITDA | 22.84B | 22.02B | 19.39B | 20.11B | 16.40B | 14.95B |
| Net Income | 6.30B | 7.02B | 3.44B | 1.68B | 3.19B | 2.61B |
Balance Sheet | ||||||
| Total Assets | 179.44B | 187.14B | 195.22B | 219.87B | 206.94B | 163.45B |
| Cash, Cash Equivalents and Short-Term Investments | 7.19B | 10.98B | 11.33B | 23.19B | 28.61B | 8.74B |
| Total Debt | 65.99B | 71.32B | 75.11B | 89.59B | 72.66B | 60.06B |
| Total Liabilities | 130.03B | 137.97B | 150.12B | 177.79B | 164.60B | 121.10B |
| Stockholders Equity | 34.46B | 33.73B | 31.75B | 28.66B | 29.65B | 28.32B |
Cash Flow | ||||||
| Free Cash Flow | 4.93B | 4.29B | 1.85B | -4.57B | -630.00M | 1.96B |
| Operating Cash Flow | 12.92B | 13.22B | 14.62B | 8.67B | 9.91B | 11.51B |
| Investing Cash Flow | -8.66B | -4.11B | -10.61B | -13.63B | -12.17B | -10.12B |
| Financing Cash Flow | -10.35B | -7.99B | -8.36B | 7.37B | 5.23B | -3.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €5.79B | 11.34 | 13.77% | 3.63% | 15.98% | 19.01% | |
71 Outperform | €8.49B | 10.49 | 15.09% | 4.24% | 6.67% | -6.79% | |
70 Outperform | €4.57B | 11.81 | 14.57% | 4.20% | -26.96% | 25.00% | |
69 Neutral | €90.39B | 14.16 | 23.22% | 4.93% | -3.10% | 26.28% | |
67 Neutral | €3.26B | 10.63 | ― | 4.78% | 10.48% | 8.87% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |